Dark Forest Capital Management LP Relay Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $977 - $1,657	69 New	69 $1,000
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $7,679 - $20,125	577 New	577 $10,000
Q1 2022 May 13, 2022	SELL	$20.26 - $32.36 $9,177 - $14,659	-453 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$26.0 - $37.03 $98,332 - $140,047	-3,782 Reduced 89.3%	453 $14,000
Q3 2021 Nov 12, 2021	BUY	$29.75 - $37.99 $125,098 - $159,747	4,205 Added 14016.67%	4,235 $134,000
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $825 - $1,145	30 New	30 $1,000

183

127M

1.7K

18K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $786M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.